Literature DB >> 477722

Vasodilator response to histamine: dependence upon the site of administration.

T M Galeno, M M Knuepfer, M J Brody.   

Abstract

Histamine causes vasodilation in part by interacting with histamine H2 receptors. The present study was undertaken to evaluate the difference in vasodilator sensitivity of H2 receptors on the inside compared to the outside of the vessel. In order to induce tone, norepinephrine was administered to an in vitro preparation of rabbit ear artery treated with mepyramine to block H1 receptors. Histamine was then either selectively perfused through the artery or added to the outside of the vessel via the organ bath. The outside of the artery was found to be twice as sensitive to the vasodilator effect of histamine as the inside. These data provide the first evidence for greater extraluminal sensitivity of vascular smooth muscle and suggest that the response to histamine will depend in part on the route the amine takes to reach receptors, e.g., from blood-borne sources or from extraluminal stores.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477722     DOI: 10.1016/0014-2999(79)90179-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation.

Authors:  F Lembeck; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

2.  In vivo characterization of histamine H1- and H2-receptors in the rat stomach microcirculation.

Authors:  A Koo
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

3.  Pulmonary vascular actions of the antihistamine oxatomide during hypoxia.

Authors:  A Tucker
Journal:  Agents Actions       Date:  1980-06

4.  The vascular responses of the isolated perfused bovine external ear to exogenous histamine and 5-HT (serotonin).

Authors:  K I Eghianruwa; P Eyre
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.